• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[喉癌中细胞增殖抗原Ki-67、与细胞凋亡及血管生成相关的蛋白p53的评估]

[Assessment of cell proliferation antigen Ki-67, protein p53 related to apoptosis and angiogenesis in laryngeal cancer].

作者信息

Gryczyński M, Kobos J, Niewiadomska H, Pietruszewska W

机构信息

Katedra i Klinika Otolaryngologii AM w Lodzi.

出版信息

Otolaryngol Pol. 2000;54 Suppl 31:191-5.

PMID:10974882
Abstract

Kinetics (growth fraction of tumour cell populations), death process of cancer cells (apoptosis and necrosis) and neovascularisation in tumour (angiogenesis) have influence on the growth of cancer. Sixty patients with laryngeal cancer treated in ENT Department of Medical Academy of Lodz were analysed. Proliferation activity of cancer cells was examined by means of selection appropriate antigen (Ki-67) characteristic for cell cycle utilising immunohistochemical techniques carried out on laryngeal cancer paraffin samples. Expression of selected protein connected with apoptosis (p-53) and intensity of angiogenesis were examine using selected antibody (anti-CD34) aimed against epithelial antigens. Above-mentioned markers were correlated with: stage of cancer progression, recurrences and metastasis of laryngeal cancer and follow-up of the patients. The morphological properties were examined as well. The researches on apoptosis, angiogenesis and proliferation of cancer cells can be used as prognostic factors for the patients with laryngeal cancer.

摘要

肿瘤细胞群体的动力学(生长分数)、癌细胞的死亡过程(凋亡和坏死)以及肿瘤中的新血管形成(血管生成)都会影响癌症的生长。对罗兹医学院耳鼻喉科治疗的60例喉癌患者进行了分析。利用在喉癌石蜡样本上进行的免疫组织化学技术,通过选择适合细胞周期的抗原(Ki-67)来检测癌细胞的增殖活性。使用针对上皮抗原的选定抗体(抗CD34)检测与凋亡相关的选定蛋白质(p-53)的表达以及血管生成强度。上述标志物与喉癌的癌症进展阶段、复发和转移以及患者随访情况相关。同时也对形态学特性进行了检查。对癌细胞凋亡、血管生成和增殖的研究可作为喉癌患者的预后因素。

相似文献

1
[Assessment of cell proliferation antigen Ki-67, protein p53 related to apoptosis and angiogenesis in laryngeal cancer].[喉癌中细胞增殖抗原Ki-67、与细胞凋亡及血管生成相关的蛋白p53的评估]
Otolaryngol Pol. 2000;54 Suppl 31:191-5.
2
[Survival of patients with laryngeal cancer and some prognostic factors].[喉癌患者的生存率及一些预后因素]
Otolaryngol Pol. 2003;57(3):329-40.
3
[Assessment of the extent of angiogenesis and proliferation and expression of selected proteins connected with apoptosis in patients with laryngeal cancer].[喉癌患者血管生成程度、增殖情况及与凋亡相关的特定蛋白质表达的评估]
Otolaryngol Pol. 2003;57(2):305-7.
4
[Significance of angiogenesis in laryngeal cancer].[血管生成在喉癌中的意义]
Otolaryngol Pol. 2000;54 Suppl 31:167-70.
5
[Programmed cell death research in laryngeal cancer].[喉癌中的程序性细胞死亡研究]
Otolaryngol Pol. 2000;54 Suppl 31:212-5.
6
Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer.金属硫蛋白、p53蛋白及Ki-67抗原表达在喉癌中的预后意义
Anticancer Res. 2007 Jan-Feb;27(1A):335-42.
7
Prognostic factors in laryngeal carcinoma: the role of apoptosis, p53, proliferation (Ki-67) and angiogenesis.
APMIS. 2003 Apr;111(4):451-7. doi: 10.1034/j.1600-0463.2003.1110401.x.
8
Tumor proliferation, p53 expression, and apoptosis in laryngeal carcinoma: relation to the results of radiotherapy.喉癌中的肿瘤增殖、p53表达及细胞凋亡:与放疗结果的关系
Cancer. 1998 Dec 15;83(12):2493-501.
9
Prognostic value of p27Kip1 expression in Basaloid Squamous Cell Carcinoma of the larynx.p27Kip1表达在喉基底样鳞状细胞癌中的预后价值
BMC Cancer. 2006 Jun 1;6:146. doi: 10.1186/1471-2407-6-146.
10
Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.Ki-67(MIB1)、p53和Lewis-X(LeuM1)作为T1和T2期喉癌复发的预后因素。
Laryngoscope. 2000 Jun;110(6):1012-7. doi: 10.1097/00005537-200006000-00024.

引用本文的文献

1
Effect of apoptotic and proliferative indices, P-glycoprotein and survivin expression on prognosis in laryngeal squamous cell carcinoma.凋亡和增殖指数、P-糖蛋白和生存素表达对喉鳞状细胞癌预后的影响。
Med Oncol. 2011 Dec;28 Suppl 1:S333-40. doi: 10.1007/s12032-010-9686-x. Epub 2010 Sep 23.